ESSA Pharma Inc.

General ticker "EPIX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $169.8M (TTM average)

ESSA Pharma Inc. does not follow the US Stock Market performance with the rate: -23.5%.

Estimated limits based on current volatility of 2.1%: low 1.69$, high 1.76$

Factors to consider:

  • Earnings expected soon, date: 2025-05-13 bmo
  • Current price 54.2% below estimated low
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-09-30 to 2026-09-30

  • 2024-09-30 to 2025-09-30 estimated range: [3.76$, 8.56$]
  • 2025-09-30 to 2026-09-30 estimated range: [2.64$, 6.38$]

Financial Metrics affecting the EPIX estimates:

  • Negative: Non-GAAP EPS, $ of -0.64 <= 0.04
  • Negative: Operating cash flow per share per price, % of -7.75 <= 1.79
  • Positive: -0.07 < Operating profit margin, % of 0
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: -1.21 < Return on assets ratio (scaled to [-100,100]) of 0
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Shareholder equity ratio, % of 97.26 > 63.75
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term EPIX quotes

2025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-061.41.51.61.71.81.9
Price $

Long-term EPIX plot with estimates

246810Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026−0.2−0.15−0.1−0.050
EPIXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-09-30 2023-09-30 2024-09-30
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $35.34MM $32.13MM $0.00MM
Operating Income $-35.34MM $-32.13MM $0.00MM
Non-Operating Income $0.13MM $5.55MM $-28.54MM
Interest Expense $0.01MM $0.01MM $0.00MM
R&D Expense $24.41MM $21.32MM $21.21MM
Income(Loss) $-35.22MM $-26.58MM $-28.54MM
Taxes $-0.11MM $0.00MM $0.00MM
Profit(Loss)* $-35.10MM $-26.58MM $-28.54MM
Stockholders Equity $167.12MM $145.63MM $124.61MM
Inventory $110.61MM $0.00MM $0.00MM
Assets $169.51MM $149.12MM $128.11MM
Operating Cash Flow $-28.70MM $-19.78MM $-22.72MM
Investing Cash Flow $-52.35MM $-3.53MM $91.79MM
Financing Cash Flow $0.25MM $-0.07MM $0.93MM
Earnings Per Share** $-0.80 $-0.60 $-0.64

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.